National Yang-Ming University
Heroes in the Medical Community Shares How Precision Medicine Constitutes Progress Toward the Development of a Personalized Medicine Business Model

Monica Bey, the chief executive officer at Business Center of Industry (left); Professor Ying-Shiung Lee of Chung Shan Medical University (middle); and President Kuo of National Yang-Ming University (right), photographed before the speech
The rapid development of the pharmaceutical industry, continual breakthroughs in genome sequencing technology, and rapid advancements in tools for big data analysis in the health industry have provided a solid foundation for the era of precision medicine.
Professor Ying-Shiung Lee has served at National Taiwan University, Chang Gung University, Taipei Tzu Chi Hospital, and China Medical University Hospital. He currently serves at Chung Shan Medical University and specializes in precision medicine. As the first of a series of Academia Liaison Serial Events of Bio-navigator __ Corporate Keynote Speech in February, Professor Lee was invited to share how precision medicine can be developed into a business model for personalized medicine. He emphasized that the focus of healthcare will shift from reactive medicine toward preventive medicine in the future.

Professor Lee indicated that the current health care system emphasizes reactive medicine in which doctors assign diagnoses and prescriptions according to patient descriptions of their symptoms and corresponding medical test results. However, in the era of precision medicine, personalized medicine constitutes a future trend for medical care. In personalized medicine, an optimal and customized medical care or preventive solution is determined by an individual’s biomarkers, lifestyle, and living environment.
Evidence suggests that several countries that provide advanced medical care have made heavy investment in precision medicine in hopes of acquiring a pioneering role in said field. The United Kingdom first introduced the 100,000 Genomes Project in 2012 with the aim of completing genome sequencing for 100,000 people and applying the obtained results to the treatment of rare diseases and cancer. The United States proposed precision medicine initiatives in 2015 and 2016 as well as Cancer Moonshot to catch up. China also included precision medicine in its Thirteenth Five-Year Plan and aimed to invest a total of RMB$60 billion by 2030.
Professor Ying-Shiung Lee is engaged in precision medicine and hopes to lead the medical community in Taiwan in progress toward achieving the mission of precision medicine for Health 4.0.
Taiwan’s biotechnology industry is undergoing critical transformation. Professor Lee hopes that precision medicine in Taiwan can rapidly develop and achieve the 6 P’s in ideal precision medicine (i.e., preventive, predictive, personalized, participatory, precision, and preemptive medicine).

Professor Ying-Shiung Lee shares with President Kuo his comprehensive plan for the academy of precision medicine for Health 4.0.
Finally, Professor Lee shares how precision medicine can be used as a business model for the application of personalized medicine. For example, the company 23andMe provides direct-to-consumer genetic tests, and Helix provides do-it-yourself genetic tests (Gene 2.0). These are examples of developed and successful cases.

其他報導

Yang-Ming Global Research & Industry Alliance – Celebrating the 20th Anniversary of the Innovation & Incubation Center Establishment

Yang-Ming National University GLORIA Enterprise Lecture 8: Observing Artistic Aesthetics from the Aspect of Brain Science - a Glimpse of the World of Neuroaesthetics

GLORIA, Yang-Ming National University Biomedical Lecture: How do Startup Companies Effectively Use Media for Marketing Purpose?

National Yang-Ming University GLORIA seized market opportunities by joining hands with its members to rattle BIO Asia 2019

GLORIA Team, National Yang-Ming University Shines at 2019 BIO International Convention, Philadelphia

The Global Research & Industry Alliance, National Yang-Ming University, Reveals Innovative Applications of Artificial Intelligence in Healthcare, Raising New Opportunities in Digital Medicine through Interdisciplinary Cooperation

National Yang Ming University Business Center of Industry-Academia Liaison Serial Events of Bio-navigator Corporate Keynote Speech

National Yang Ming University Business Center of Industry-Academia Liaison Serial Events of Bio-navigator Corporate Keynote Speech

The Global Research & Industry Alliance, National Yang-Ming University/Far Eastern Memorial Hospital Conduct a Call for Proposals Orientation to Assist in the Commercialization of Clinical ResearchDevelopment Outcomes

National Yang-Ming University Gloria / Cheng Hsin General Hospital’s Counseling & Funding Orientation Encouraged Commercialization of Research Products

National Yang Ming University GLORIA - Big Data Corporate Keynote Speech - The Next Digital Wave: OpportunitiesChallenges

National Yang Ming University Business Center of Industry-Academia Liaison Serial Events of Bio-navigator -Three ASUS Life Services Provide SmartPrecision Medicine

Aging Carefree 20 International Experts from the Joint Team of Taipei Veterans General Hospital & National Yang-Ming University Gather Together to Open the Black Box of an Ageless Future

2018 Innovation Medical Device Development Technology Exchange Exhibition Creates New Opportunities for Domestic Medical-Equipment Manufacturers
